MC

Mahesh Channabasappa Nalwad

Active Director Director DIN 02603689
DIN 02603689 First appointment Jun 2001 Primary industry Non-Profit Organizations
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Jun 2001
Shareholding value •••• Premium profile

About Mahesh Channabasappa Nalwad

Data last updated:

Mahesh Channabasappa Nalwad is a Director at Unnathi Diagnostic And Scan Centre Private Limited (since 2022) and Designated Partner at Hermes Lifescience Llp (since 2021). The companies operate in Non-Profit Organizations, Healthcare and Financial Services. The largest current company by reported revenue is Unnathi Diagnostic And Scan Centre Private Limited at ₹89.2 Lakh (FY 2024). Earlier, Mahesh Channabasappa Nalwad was a Director at Hubli Scan Centre Private Limited (2001–2015) and Director at Munakka Products Private Limited (2007–2018) and 2 more.

DIN 02603689
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 19 Jun 2001
Oldest Company Age 20 yrs
Largest company Unnathi Diagnostic And Scan Centre Private Limited · ₹89.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Aug 20222022₹89.2 Lakh (FY 2024)Active
Designated Partner17 Mar 20212020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hubli Scan Centre Private Limited U85110KA2001PTC029063
Director19 Jun 20012001₹10.86 Cr (FY 2024)Active
Munakka Products Private Limited U15100KA1989PTC010183
Director28 Sep 20071989₹8.5 Lakh (FY 2020)Active
Director06 Jan 20112011₹97.77 Cr (FY 2025)Active
Twin-City Hospital Private Limited U85110KA2006PTC038664
Director03 Mar 20062006Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hermes Lifescience Llp
Twin-City Hospital Private Limited
Unnathi Diagnostic And Scan Centre Private Limited
Hubli Scan Centre Private Limited
Premium access

Shareholding and investment profile for Mahesh Channabasappa Nalwad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Channabasappa Nalwad

Mahesh Channabasappa Nalwad currently holds 2 directorships: Unnathi Diagnostic And Scan Centre Private Limited (Director, since 18 Aug 2022, revenue ₹89.2 Lakh (FY 2024)); Hermes Lifescience Llp (Designated Partner, since 17 Mar 2021).

Mahesh Channabasappa Nalwad was first appointed on 19 Jun 2001 as Director at Hubli Scan Centre Private Limited. The most recent appointment on record is 18 Aug 2022 at Unnathi Diagnostic And Scan Centre Private Limited.

Mahesh Channabasappa Nalwad held 4 earlier board appointments: Hubli Scan Centre Private Limited (Director, 19 Jun 2001 to 17 Jun 2015); Munakka Products Private Limited (Director, 28 Sep 2007 to 28 Mar 2018); Suchirayu Health Care Solutions Limited (Director, 06 Jan 2011 to 17 Jun 2015); Twin-City Hospital Private Limited (Director, from 03 Mar 2006).

The current boards of Mahesh Channabasappa Nalwad's companies include Mailareshwar Jeevanna Jeevannavar (Unnathi Diagnostic And Scan Centre Private Limited), Prashant Basavanthappa Channaveerappanavar (Unnathi Diagnostic And Scan Centre Private Limited), Siddanagouda Anandgouda Patil (Unnathi Diagnostic And Scan Centre Private Limited), Vasudevamurthy Kariganur Venkatesha (Unnathi Diagnostic And Scan Centre Private Limited), Devaraj Hanamagowda Patil (Hermes Lifescience Llp), Harsha Virendra Bhasme (Hermes Lifescience Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available